Correcting COVID-19 Risk Misperceptions via Information Provision

How to cite

Nakata, Taisuke; Chiba, Asako; Haganuma, Kazuya; Nguyen, Thuy Linh; Takaku, Reo. 2026. "Correcting COVID-19 Risk Misperceptions via Information Provision." AEA RCT Registry. AEARCTR-0017584. https://doi.org/10.1257/rct.17584-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Taisuke Nakata* , Asako Chiba , Kazuya Haganuma , Thuy Linh Nguyen , Reo Takaku

* Primary investigator

Registry ID
AEARCTR-0017584
DOI
https://doi.org/10.1257/rct.17584-1.0
First registered
Last updated
Status
Completed
Trial dates
2023-04-25 – 2023-04-27
Countries
Japan ()
JEL codes
I10
Registry record
http://www.socialscienceregistry.org/trials/17584

Abstract

We conducted an information provision experiment in April 2023 in Japan to investigate how different types of information affect people's subjective assessment of COVID-19 related risks. The majority of respondents overestimate infection and fatality risks. Recent infection-related statistics lower risk perceptions if presented in percentage, but do not lower them if presented in levels. Providing pessimistic outlooks raises risk perceptions. We also find substantial heterogeneity in the response to information provision across various individual characteristics, such as age, gender, education, marital status, health status, COVID-19-related experiences, and vaccination status.

Intervention

Provide information about COVID-19 infection and fatality risks.

Experimental design

We divide participants into four groups. We do not provide Group 1---the control group---with any information. Meanwhile, we provide Group 2 with the recent total infected cases and deaths (referred to as ``level'' information). We provide Group 3 with the recent actual probabilities of getting infected and dying from COVID-19 once infected (``percentage'' information). Finally, we provide Group 4 with qualitative information about a possible future path of new infection (``qualitative'' information). Below is the exact wording for these three types of information:

Level information: From mid-March 2023 to mid-April 2023 in Japan, the total infected cases is 226,007. From April 2022 to March 2023 in Japan, the total deaths were 45,727.

Percentage information: From mid-March 2023 to mid-April 2023 in Japan, the actual infection rate is 0.18\%. From April 2022 to March 2023 in Japan, the actual fatality rate is 0.17\%.

Qualitative information: The number of new cases has been gradually increasing, and there is concern about the spread of infection after the holidays in May. On April 19, the expert group mentioned the possibility of a 9th wave, which would be larger than the 8th wave. Compared to the 6th and 7th waves (January-April 2022 and July-September 2022), the 8th wave (November 2022-February 2023) showed an increase in fatality rate.

After providing information about COVID-19, we ask participants about their perceptions of infection or fatality risks, namely, the subjective probability of being infected with COVID-19 within the next month and the probability of fatality if infected with COVID-19. For both infection and fatality risks, we present participants with the following response options: (1) less than 0.001%, (2) 0.001% to less than 0.01%, (3) 0.01% to less than 0.1%, (4) 0.1% to less than 1%, (5) 1% to less than 5%, (6) 5% to less than 10%, (7) 10% to less than 20%, (8) 20% to less than 50%, (9) 50% or higher.

We ask participants about their background demographic and socio-economic characteristics, including age, gender, place of residence, education level, marital status, health condition (whether they have chronic diseases), and the primary source of media (television, newspaper, internet, SNS, or others). We also ask about their COVID-19-related experiences, including vaccination status, the number of past infections, and whether they have any acquaintances who died from the virus.

Design details

Randomization method
By computer
Randomization unit
10,000
Clusters
10,000 individuals
Observations
10,000 individuals
Arms
2,500 for each treatment group (one control group and three treatment groups)
Primary outcomes
Respondents' perceptions on COVID-19 infection and fataility risks

Cited by

No citation data available for this registration yet.

Keywords